Anti-LYAM3/ SELP/ CD62 monoclonal antibody
Anti-LYAM3/ SELP/ CD62 antibody for FACS & in-vivo assay
Go to SELP/SELP products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-T10965-Ab-1/ GM-Tg-hg-T10965-Ab-2 | Anti-Human SELP monoclonal antibody | Human |
GM-Tg-rg-T10965-Ab-1/ GM-Tg-rg-T10965-Ab-2 | Anti-Rat SELP monoclonal antibody | Rat |
GM-Tg-mg-T10965-Ab-1/ GM-Tg-mg-T10965-Ab-2 | Anti-Mouse SELP monoclonal antibody | Mouse |
GM-Tg-cynog-T10965-Ab-1/ GM-Tg-cynog-T10965-Ab-2 | Anti-Cynomolgus/ Rhesus macaque SELP monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-T10965-Ab-1/ GM-Tg-felg-T10965-Ab-2 | Anti-Feline SELP monoclonal antibody | Feline |
GM-Tg-cang-T10965-Ab-1/ GM-Tg-cang-T10965-Ab-2 | Anti-Canine SELP monoclonal antibody | Canine |
GM-Tg-bovg-T10965-Ab-1/ GM-Tg-bovg-T10965-Ab-2 | Anti-Bovine SELP monoclonal antibody | Bovine |
GM-Tg-equg-T10965-Ab-1/ GM-Tg-equg-T10965-Ab-2 | Anti-Equine SELP monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-T10965-Ab-1/ GM-Tg-hg-T10965-Ab-2; GM-Tg-rg-T10965-Ab-1/ GM-Tg-rg-T10965-Ab-2; GM-Tg-mg-T10965-Ab-1/ GM-Tg-mg-T10965-Ab-2; GM-Tg-cynog-T10965-Ab-1/ GM-Tg-cynog-T10965-Ab-2; GM-Tg-felg-T10965-Ab-1/ GM-Tg-felg-T10965-Ab-2; GM-Tg-cang-T10965-Ab-1/ GM-Tg-cang-T10965-Ab-2; GM-Tg-bovg-T10965-Ab-1/ GM-Tg-bovg-T10965-Ab-2; GM-Tg-equg-T10965-Ab-1/ GM-Tg-equg-T10965-Ab-2 |
Products Name | Anti-SELP monoclonal antibody |
Format | mab |
Target Name | SELP |
Protein Sub-location | Transmembrane Protein |
Category of antibody | FACS/Biofunctional Antibody, Therapeutics Target antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-SELP benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Biosimilar | GMP-Bios-ab-123 | Pre-Made Crizanlizumab biosimilar, Whole mAb, Anti-SELP Antibody: Anti-CD62/CD62P/GMP140/GRMP/LECAM3/PADGEM/PSEL therapeutic antibody |
Biosimilar | GMP-Bios-ab-270 | Pre-Made Inclacumab biosimilar, Whole mAb, Anti-SELP Antibody: Anti-CD62/CD62P/GMP140/GRMP/LECAM3/PADGEM/PSEL therapeutic antibody |
Biosimilar | GMP-Bios-INN-1027 | Pre-Made Torapsel Biosimilar, Fusion Protein targeting SELP fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting CD62/CD62P/GMP140/GRMP/LECAM3/PADGEM/PSEL |
Target Antigen | Products Developing | Multi-species LYAM3/ SELP/ CD62 VLP (virus-like particle) (Products Developing) |
ORF Viral Vector | pGMLPm004369 | mouse Selp Lentivirus plasmid |
ORF Viral Vector | vGMLPm004369 | mouse Selp Lentivirus particle |
Target information
Target ID | GM-T10965 |
Target Name | SELP |
Gene ID | 6403,20344,25651,701277,403994,101083565,281486,100009695 |
Gene Symbol and Synonyms | CD62,CD62P,GMP-140,GMP140,GRMP,LECAM3,PADGEM,PSEL,PSELECT,SELP |
Uniprot Accession | P16109,P98106,P42201 |
Uniprot Entry Name | LYAM3_HUMAN,LYAM3_RAT,LYAM3_BOVIN |
Protein Sub-location | Transmembrane Protein |
Category | Therapeutics Target, INN Index |
Disease | Hodgkin's lymphoma, Sepsis |
Gene Ensembl | ENSG00000174175 |
Target Classification | N/A |
The target: SELP, gene name: SELP, also named as CD62, CD62P, GMP140, GRMP, LECAM3, PADGEM, PSEL. This gene encodes a 140 kDa protein that is stored in the alpha-granules of platelets and Weibel-Palade bodies of endothelial cells. This protein redistributes to the plasma membrane during platelet activation and degranulation and mediates the interaction of activated endothelial cells or platelets with leukocytes. The membrane protein is a calcium-dependent receptor that binds to sialylated forms of Lewis blood group carbohydrate antigens on neutrophils and monocytes. Alternative splice variants may occur but are not well documented. [provided by RefSeq, Jul 2008].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.